Going Public on Nasdaq and Therapeutics for Difficult-to-Treat Cancers

Subscribe to The Global Herald in Google News

Nasdaq published this video item, entitled “Going Public on Nasdaq and Therapeutics for Difficult-to-Treat Cancers” – below is their description.

Pyxis Oncology CEO Dr. Lara Sullivan joins Jill Malandrino on Nasdaq #TradeTalks to discuss going public on Nasdaq and therapeutics for difficult-to-treat cancers.

Nasdaq YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

Subscribe to The Global Herald in Google News

About This Source - Nasdaq

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates three stock exchanges in the United States: the namesake Nasdaq stock exchange, the Philadelphia Stock Exchange, and the Boston Stock Exchange, and seven European stock exchanges: Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, and Nasdaq Vilnius. It is headquartered in New York City, and its president and chief executive officer is Adena Friedman.

Recent from Nasdaq:

  • The Four Biotech Names That Are Included in the Nasdaq-100
  • The Evolving Global Tax Landscape and How It Could Impact Investment Patterns
  • Trends in the Nasdaq-100 Volatility Index and Portfolio Diversification in a Rising Rate Environment
  • Leave a Comment

    We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.